GNS-1653

N/A

Report date: 2023/05/05 17:09:36
NME

Base Information

Drug NameGNS-1653
Drug Alias NameGNS-1653
ClassificationSmall molecules
Mechanisms of ActionSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsLymphoma, T-Cell, Peripheral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenosco
China Registration ClassN/A

Develop Information

Active CompaniesGenosco
Inactive CompaniesN/A
Active IndicationsLymphoma, T-Cell, Peripheral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A